Leo Bastiaens1. 1. Family Services of Western Pennsylvania, University of Pittsburgh, 33 Sunnyhill Drive, Pittsburgh, PA 15228, USA. Bastiaensl@aol.com
Abstract
OBJECTIVE: To evaluate change in quality of life in a community clinic ADHD population treated with atomoxetine or stimulants. No direct comparisons between atomoxetine and stimulants to improve quality of life in ADHD are available. METHODS: A prospective, nonrandomized comparison between ADHD patients treated with atomoxetine or stimulants in one clinic. Structured diagnostic assessment tools and a specific quality of life measure were used. RESULTS: 84 patients (atomoxetine n = 39/stimulants n = 45), between the ages of 5 and 18, were treated for approximately 8 months. At end point, there were no significant differences in improvements of quality of life between the two groups. Age, participation in psychotherapy, and parental disability were not correlated with quality of life changes. Patients with lower baseline scores improved most. CONCLUSIONS: Both atomoxetine and stimulants led to a modest increase in quality of life in this community clinic ADHD population.
OBJECTIVE: To evaluate change in quality of life in a community clinic ADHD population treated with atomoxetine or stimulants. No direct comparisons between atomoxetine and stimulants to improve quality of life in ADHD are available. METHODS: A prospective, nonrandomized comparison between ADHDpatients treated with atomoxetine or stimulants in one clinic. Structured diagnostic assessment tools and a specific quality of life measure were used. RESULTS: 84 patients (atomoxetine n = 39/stimulants n = 45), between the ages of 5 and 18, were treated for approximately 8 months. At end point, there were no significant differences in improvements of quality of life between the two groups. Age, participation in psychotherapy, and parental disability were not correlated with quality of life changes. Patients with lower baseline scores improved most. CONCLUSIONS: Both atomoxetine and stimulants led to a modest increase in quality of life in this community clinic ADHD population.
Authors: Daniel Geller; Craig Donnelly; Frank Lopez; Richard Rubin; Jeffrey Newcorn; Virginia Sutton; Rosalie Bakken; Martin Paczkowski; Douglas Kelsey; Calvin Sumner Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-09 Impact factor: 8.829
Authors: Amy R Perwien; Douglas E Faries; Christopher J Kratochvil; Calvin R Sumner; Douglas K Kelsey; Albert J Allen Journal: J Dev Behav Pediatr Date: 2004-08 Impact factor: 2.225
Authors: Peter M Wehmeier; Alexander Schacht; Rodrigo Escobar; Nicola Savill; Val Harpin Journal: Child Adolesc Psychiatry Ment Health Date: 2010-12-06 Impact factor: 3.033
Authors: Oscar G Bukstein; L Eugene Arnold; Jeanne M Landgraf; Paul Hodgkins Journal: Child Adolesc Psychiatry Ment Health Date: 2009-12-10 Impact factor: 3.033